Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$0.70 and traded as low as C$0.26. Aptose Biosciences shares last traded at C$0.26, with a volume of 12,554 shares changing hands.
Aptose Biosciences Stock Down 7.1 %
The company has a debt-to-equity ratio of 670.80, a current ratio of 0.80 and a quick ratio of 5.41. The company has a fifty day moving average price of C$0.43 and a 200 day moving average price of C$0.70. The company has a market cap of C$4.71 million, a PE ratio of -0.04 and a beta of 1.36.
Aptose Biosciences Company Profile
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Recommended Stories
- Five stocks we like better than Aptose Biosciences
- Consumer Discretionary Stocks Explained
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
